N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
A Rubio-Casillas, D Cowley, M Raszek… - International Journal of …, 2024 - Elsevier
Due to the health emergency created by SARS-CoV-2, the virus that causes the COVID-19
disease, the rapid implementation of a new vaccine technology was necessary. mRNA …
disease, the rapid implementation of a new vaccine technology was necessary. mRNA …
[HTML][HTML] Omicron XBB. 1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
MJ López Fernández, S Narejos, A Castro… - Vaccines, 2024 - mdpi.com
(1) Background: The global coronavirus disease 2019 vaccination adapts to protect
populations from emerging variants. This communication presents interim findings from the …
populations from emerging variants. This communication presents interim findings from the …